MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cellectis SA Company Profile (NASDAQ:CLLS)

Consensus Ratings for Cellectis SA (NASDAQ:CLLS) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $47.80 (51.99% upside)

Analysts' Ratings History for Cellectis SA (NASDAQ:CLLS)
Show:
DateFirmActionRatingPrice TargetActions
5/16/2016OppenheimerReiterated RatingBuy$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2016Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/5/2016Ladenburg ThalmannInitiated CoverageBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016SunTrustInitiated CoverageBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2015Bank of AmericaInitiated CoverageBuy$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015Jefferies GroupInitiated CoverageBuy$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha